mothers with anti-HBe the incidence of perinatal transmission of hepatitis B virus is much lower, estimates varying between 10% and 20/.4 -6 The prevalence of HBsAg, anti-HBe positive women, however, is about five times that of HBsAg, HBeAg positive mothers.5 6 Because of the relatively high proportion of HBsAg, anti-HBe positive mothers the number of children infected with hepatitis B virus from this source should not be neglected. It is, however, important that according to several reports infants of anti-HBe positive mothers develop chronic HBs antigenaemia only in a small minority of cases,6 but the manifestations of the disease vary from usually asymptomatic to fulminant hepatitis.7 8 In view of the (albeit infrequent) occurrence of severe disease in children of anti-HBe positive mothers we, like others,9 '0 suggest that all neonates of HBsAg positive mothers should be candidates for immunisation against hepatitis B infection. Current costs of active immunisation, however, may prevent general acceptance of this until a cheaper vaccine becomes available.
tomography. At baseline evaluation 27 women showed radiological evidence of pituitary adenoma; at the end of the follow up period the number had increased to 41. Amenorrhoea, steady and raised serum prolactin concentrations, a low ratio of luteinising hormone to follicle stimulating hormone, a longer duration of disease, and low serum progesterone concentrations were more common in women with a final diagnosis of pituitary adenoma than in those whose sella remained normal. Tests for release of prolactin had yielded abnormal results from the outset in all 41 women with radiological evidence of pituitary adenoma and in about half of those whose sella had remained radiologically normal. Response to medical treatment (metergoline in 20 patients, bromocriptine in 21) was similar and showed no difference between patients with tumorous and non-tumorous hyperprolactinaemia.
These findings suggest that a large proportion of women with hyperprolactinaemia may harbour a prolactin secreting pituitary adenoma which becomes apparent over a relatively short period. Amenorrhoea and steady and raised serum prolactin concentrations are more common in these women. Tests for release of prolactin are of predictive value in identifying women who will develop a pituitary adenoma.
Introduction
Hyperprolactinaemia induces amenorrhoea, galactorrhoea, and infertility and may be due to pituitary adenoma or be a functional (idiopathic) disorder. The natural history of hyperprolactinaemia is not known,' and the rate of growth of microadenomas is a subject of controversy.2 3 With large adenomas the diagnosis is easy, but this is not so with small prolactin secreting adenomas (microadenomas). Minor changes of the sella turcica detected by sellar tomography have been taken as evidence of microadenoma,4 but with both sellar tomography and computed tomography (CT) false negative and false positive results may occur.5 6 In addition, permanently raised serum prolactin concentrations 7 and the absence of response of prolactin to provocative stimuli (protirelin; thyrotrophin releasing hormone), cimetidine, and benserazide)8-0 and to inhibiting stimuli (nomifensine and levodopa-carbidopa)" 12 have also reportedly been shown to characterise patients with prolactin secreting pituitary adenomas. The validity of such tests has been questioned, however, since an absent prolactin response may also be observed in patients with a normal radiological appearance of the sella."
With the assumption that patients with hyperprolactinaemia might be harbouring a microadenoma which was still too small to be seen we decided to follow up 13 14 in 37 women, and with nomifensine (200 mg orally)" in 28 patients.
In 41 women medical treatment was instituted with metergoline (20 cases; 8-12 mg/day)'5 or bromocriptine (21 cases; 5-10 mg/day),16 and after at least 90 days efficacy established as: no result; menses; ovulatory menses; pregnancy. All patients were followed up for three years by means of sellar tomography or CT, or both, performed yearly. Results of sellar tomography were evaluated by two independent neuroradiologists using the criteria of Vezina and Sutton.4 Close attention was paid to changes in the sella on repeated examinations (performed under standardised conditions and with the same instrument) rather than to abnormalities seen at a single examination, which might have been due to anatomical variation. With CT a microadenoma was defined as th', presence of a hypodense round or oval area within the hypophysis after intravenous injection of contrast media: additional criteria were the displacement of the pituitary stalk or erosions of the bony structures.
In the benserazide, protirelin, and cimetidine tests a normal prolactin response was defined as doubling of baseline prolactin values8 10; in the nomifensine test a normal response was defined as a mean prolactin concentration at 120, 180, and 240 minutes, at least 330,, lower than baseline." Serum prolactin, FSH, LH, progesterone, 17p-oestradiol, and testosterone concentrations were determined by specific radioimmunoassays; in our hands the interassay coefficients of variation vary from 5 8o`for progesterone to 7 50!`for testosterone and the intra-assay coefficients of variation vary from 4-0°o for prolactin to 6-6°o for progesterone.
Statistical analysis was by Student's t test for unpaired data and the x2 test.
Results
At baseline evaluation 41 patients were found to-have a normal sella, as assessed by sellar tomography or CT, and 27 patients showed evidence of pituitary adenoma. Table I gives the details of the two groups. Prolactin concentrations were found to be steady in each group, but the actual mean values differed significantly (p<0 02). Also the mean LH/FSH ratio and serum progesterone concentration were lower in patients with radiological evidence of pituitary tumour, whereas no significant differences were found in the age of the patients, prevalence of amenorrhoea, duration of the clinical condition, or serum testosterone or 17,p-oestradiol concentration. Testing for release of prolactin showed no modification with any agent in patients with evidence of adenoma; however, a preponderance of absent prolactin responses to each test was also found in most patients with a normal radiological appearance of the sella turcica.
At the end of the follow up period there was an impressive increase in the number of patients with radiological evidence of pituitary adenoma as detected by sellar tomography or CT, the final number having reached 41 cases. In two cases in which appearances on sellar tomography had suggested a diagnosis of adenoma CT allowed a final diagnosis of empty sella. Of 15 women with a final diagnosis of adenoma and who had had a normal sella at the outset, 11 had been evaluated by both sellar tomography and CT, six of them simultaneously. In three patients in the latter group CT detected a pituitary adenoma earlier than did sellar tomography, and in the others detection occurred at the same time. Surgical exploration was attempted in eight patients, and in every one a pituitary adenoma was confirmed. Of these eight patients, six had had radiological evidence of adenoma from the outset. Effects of treatment-A total of 41 patients were treated with either metergoline or bromocriptine. Of these, four achieved no benefit, while menses were induced in 13 and ovulatory menses in 11; 12 patients became pregnant. Therapeutic outcome was independent of the final radiological diagnosis, basal prolactin concentration, and drug used. Pregnancy occurred in both cases of empty sella. Though beyond the original aims of the study, the possible effect of medical treatment on the development of a pituitary adenoma was evaluated retrospectively. Of 15 patients whose sella remained normal radiologically, 11 had been treated with either metergoline or bromocriptine; of 15 patients whose sella changed in appearance, 13 had been treated with either drug (difference not significant).
Discussion
In patients with hyperprolactinaemia one of the greatest difficulties is in differentiating between functional hyperprolactinaemia and pituitary adenoma. Attempts to characterise the disease have been based on serial determinations of serum prolactin concentrations and the response of prolactin to stimulating and inhibiting agents, but the validity of these approaches has been questioned.7 i2 Radiological evaluation of the sella turcica has been greatly improved by high resolution computed tomography, which has replaced traditional invasive diagnostic procedures such as pneumoencephalography and cerebral angiography. A firm criterion for radiological diagnosis of pituitary adenomas, however, is not available.' Unfortunately, the natural history of hyperprolactinaemia is not known.' Functional hyperprolactinaemia and pituitary adenoma may represent two different entities or be consecutive stages of the same disorder." Anecdotal evidence indicates that some cases of functional hyperprolactinaemia will be followed by detection of a pituitary prolactin secreting pituitary adenoma.2 3 13 1 71 i The need for early diagnosis of a prolactin secreting adenoma lies in the fact that cure is obtained only by operation at an early stage,'9 although even then recurrence of hyperprolactinaemia is common.20 On the other hand, the surgical approach is often refused by patients unless serious local disturbances are present-for example, severe headache or visual field defects.
In our study 68 women with hyperprolactinaemia were followed up for three years; the number with radiological evidence of pituitary adenoma increased from 27 (39-7%) to 41 (603"1%). That so many cases were detected was probably due to the extensive use of combined sellar tomography and CT scans; some patients were initially examined by sellar tomography and later by CT scan, but in most instances changes were observed with repeated use of the same technique.
At the end of the follow up period there were clear differences between patients with and without radiological evidence of tumour which had not been present at the baseline evaluation. Amenorrhoea, a longer duration of disease, steady and raised prolactin concentrations, a low LH/FSH ratio, and low serum progesterone concentrations had been more common in patients with radiological evidence of adenoma than in patients whose sella remained normal. In addition, in about half of the patients with a normal sella prolactin had shown no response to the various tests. A significant spontaneous decrease of basal prolactin concentrations was observed only in patients with a normal prolactin response to the tests (table II) . Interestingly six of the seven patients with iatrogenic hyperprolactinaemia were in the latter group.
In patients with a persistently normal sella and no prolactin response to the various tests the non-responsiveness might be idiopathic. We, however, could not find a normal subjectmale or female-who did not respond to each of the tests, which suggests another interpretation-that these patients harbour an extremely slow growing pituitary (micro)adenoma. Cases 
Abstract
A study was conducted investigating the possibility that the immunosuppressive action of methimazole (the active metabolite of the antithyroid drug carbimazole) might be due to an effect on the production of oxygen radicals by monocytes. Techniques comprised measurement of luminol dependent chemoluminescence in monocytes and a spectrophotometric assay for production of hydrogen peroxide.
The results showed definite inhibition of formation of oxygen radicals by resting and stimulated monocytes, which may explain the immunosuppressive action of the drug in Graves' disease. The findings also suggest that the formation of oxygen radicals and the initiation of the immune response may be closely related.
Introduction
Phagocytic and chemotactic stimuli such as opsonised zymosan and phorbol myristate acetate provoke a respiratory burst in macrophages and polymorphonuclear leucocytes characterised by an increase in oxygen consumption, activation of the hexose monophosphate shunt, and generation of oxygen radicals.' Formation of superoxide anion (0,-), the first of these radicals, is apparently catalysed by a membrane bound reduced form of nicotinamide adenine dinucleotide phosphate oxidase and a unique b cytochrome.1 2 This is followed by dismutation of O.2 to hydrogen peroxide (H 202) and various further reactions which yield the highly reactive oxygen metabolites hydroxyl radical (OH-), singlet oxygen (102), and hypochlorite anion (OC1-).3
Although the role of these active oxygen species in microbial killing and cytotoxicity is established,3 their possible effects on other immune responses such as antibody production have received much less attention.
We recently showed that methimazole, the active metabolite of the antithyroid drug carbimazole, is an immunosuppressant which inhibits antibody production by an action on antigen presenting monocytes. 5 We have now investigated the possibility that this might be due to an effect on the production of oxygen radicals by these cells, since intracellular peroxidase is linked to the uptake of methimazole by cells6 and inhibition of peroxidase within the thyroid follicular cell has been proposed as the primary mechanism of the drug's antithyroid activity.7 In this
